Researches

Displaying 6281 - 6290 of 16330

Research Plan

# Title Department Research Year
6281 Multidisciplinary decision making in the management of
hepatocellular carcinoma: A hospital-based study 		Department of Gastroenterology and Tropical Medicine 2015
6282 Multidisciplinary decision making in the management of
hepatocellular carcinoma: A hospital-based study 		Department of Gastroenterology and Tropical Medicine 2015
6283 Navelbine and Capecitabine (Navcap) Followed either by Navcap or by Weekly Docetaxel in the First-Line Treatment of HER-2/neu Negative Metastatic Breast Cancer Department of Rheumatology ,Rehabilitation & physical medicine 2015
6284 Navelbine and Capecitabine (Navcap) Followed either by Navcap or by Weekly Docetaxel in the First-Line Treatment of HER-2/neu Negative Metastatic Breast Cancer Department of Rheumatology ,Rehabilitation & physical medicine 2015
6285 Navelbine and Capecitabine (Navcap) Followed either by Navcap or by Weekly Docetaxel in the First-Line Treatment of HER-2/neu Negative Metastatic Breast Cancer Department of Rheumatology ,Rehabilitation & physical medicine 2015
6286 Navelbine and Capecitabine (Navcap) Followed either by Navcap or by Weekly Docetaxel in the First-Line Treatment of HER-2/neu Negative Metastatic Breast Cancer Department of Rheumatology ,Rehabilitation & physical medicine 2015
6287 NAVELBLINE AND CAPECITABINE (NAVCAP) FOLLOWED EITHER BY NAVCAP OR BY WEEKLY DOCETAXEL IN THE FIRST-LINE TREATMENT OF HER-2/NEU NEGATIVE METASTATIC BREAST CANCER. Department of Rheumatology ,Rehabilitation & physical medicine 2015
6288 NAVELBLINE AND CAPECITABINE (NAVCAP) FOLLOWED EITHER BY NAVCAP OR BY WEEKLY DOCETAXEL IN THE FIRST-LINE TREATMENT OF HER-2/NEU NEGATIVE METASTATIC BREAST CANCER. Department of Rheumatology ,Rehabilitation & physical medicine 2015
6289 NAVELBLINE AND CAPECITABINE (NAVCAP) FOLLOWED EITHER BY NAVCAP OR BY WEEKLY DOCETAXEL IN THE FIRST-LINE TREATMENT OF HER-2/NEU NEGATIVE METASTATIC BREAST CANCER. Department of Rheumatology ,Rehabilitation & physical medicine 2015
6290 NAVELBLINE AND CAPECITABINE (NAVCAP) FOLLOWED EITHER BY NAVCAP OR BY WEEKLY DOCETAXEL IN THE FIRST-LINE TREATMENT OF HER-2/NEU NEGATIVE METASTATIC BREAST CANCER. Department of Rheumatology ,Rehabilitation & physical medicine 2015